Skip to main content
Premium Trial:

Request an Annual Quote

New Subscriptions Drive Up Gene Logic s Q1 Revenues, Losses Widen

NEW YORK, April 30 - Driven by four new subscriptions to its GeneExpress database, Gene Logic reported a 54 percent increase in first quarter 2001 revenues to $8.2 million, compared with $5.3 million in the year ago quarter.

"The company's progress on all fronts is consistent with our goal of aggressively driving the business towards profitability and successful commercialization of our information products," Philip Rohrer, Gene Logic's chief financial officer, said in a statement. "Our pipeline of prospective customers continues to expand while we devote our resources to increasing
our database content and capabilities."

The company signed on two Japanese companies, Sumitomo Pharmaceuticals and Sankyo as subscribers to the full GeneExpress suite and added IDEC Pharmaceuticals and Genentech as subscribers to its database subsets. This brings the total number of GeneExpress subscribers to 16, the company said.

During the quarter the company's expenses also rose to $20.9 million, up from $12.3 million for the year-ago quarter. R&D expenses from the expansion of the company's databases, which rose to $15.7 million from $8.5 million, accounted for the bulk of this increase. Sales, general, and administrative expenses rose modestly to $4.8 million from $3.4 million in the first quarter of 2000. Amortization of goodwill remained flat at $381,000.

Gene Logic's losses widened during the quarter to $10.6 million, or 40 cents per share, from $6 million or 20 cents per share for the first quarter of 2000. These losses beat Wall Street's expectations of 41 cents per share by a penny, according to a poll of brokers conducted by FirstCall/Thomson Financial.

Gene Logic plans to continue to expand its databases during the remainder of the year, Rohrer said.

As of March 31, the company reported $213.8 million in cash and cash equivalents.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.